-       Report 
- October 2024
-  69 Pages 
- Global 
   From       €3126EUR$3,495USD£2,750GBP 
          -       Report 
- September 2024
-  115 Pages 
- Global 
   From       €13412EUR$14,995USD£11,798GBP 
          -       Clinical Trials 
- August 2024
-  70 Pages 
- Global 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Clinical Trials 
- July 2024
-  458 Pages 
- Global 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- June 2024
-  80 Pages 
- Global 
   From       €3126EUR$3,495USD£2,750GBP 
           -       Report 
- May 2024
-  67 Pages 
- Global 
   From       €3126EUR$3,495USD£2,750GBP 
          -       Report 
- December 2023
-  78 Pages 
- Global 
   From       €3126EUR$3,495USD£2,750GBP 
          -       Report 
- November 2023
-  1203 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- September 2023
-  1105 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- January 2023
-  1469 Pages 
- Global 
   From       €4472EUR$5,000USD£3,934GBP 
          -       Report 
- December 2022
-  69 Pages 
- Global 
   From       €3126EUR$3,495USD£2,750GBP 
          -       Report 
- November 2022
-  244 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- November 2022
-  624 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- November 2022
-  107 Pages 
- Global 
   From       €3533EUR$3,950USD£3,108GBP 
          -       Report 
- November 2021
-  108 Pages 
- Global 
   From       €13412EUR$14,995USD£11,798GBP 
            -       Report 
- October 2025
- China 
   From       €1874EUR$2,095USD£1,648GBP 
      €3569EUR$3,990USD£3,139GBP 
            -       Report 
- October 2025
- United Kingdom 
   From       €1874EUR$2,095USD£1,648GBP 
      €3569EUR$3,990USD£3,139GBP 
          -       Report 
- October 2024
-  73 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
            -       Report 
- December 2023
-  180 Pages 
- Global 
   From       €1118EUR$1,250USD£983GBP 
      €2236EUR$2,500USD£1,967GBP 
          -       Report 
- December 2023
-  80 Pages 
- United States 
   From       €1342EUR$1,500USD£1,180GBP 
       
       The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include    Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less   Read more